Status:
COMPLETED
Study Evaluating The Effect of Bosutinib (SKI-606) On Cardiac Repolarization (Rhythms Of The Heart)
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Healthy Subjects
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to examine the effect of SKI-606 on rhythms of the heart (cardiac repolarization)
Eligibility Criteria
Inclusion
- Inclusion Criteria: Men or women of nonchildbearing potential; 18-50 years old; healthy as determined by the investigator, including physical examination, laboratory test results, and medical history.
Exclusion
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2009
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00914121
Start Date
June 1 2009
End Date
August 1 2009
Last Update
September 2 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tacoma, Washington, United States, 98418